Fig. 1
From: Chronotype: what role in the context of gastroenteropancreatic neuroendocrine tumors?
The individual differences in chronotype score and percentage of chronotype in GEP-NET patients compared to the control group. GEP-NET patients have a lower chronotype score and a higher percentage of evening chronotype than controls. In addition, grouped GEP-NET patients according to chronotype categories, most of the participants had a morning chronotype (n = 53, 48.6%), followed by evening type (n = 37, 33.9%), and finally the neither chronotype (n = 19, 17.4%). Difference in chronotype score was analysed by paired Student’s t test, while differences in chronotype categories were analysed by chi-square (χ2) test. *A p value in bold type denotes a significant difference (p < 0.05). GEP-NET, gastroenteropancreatic-neuroendocrine tumors